Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and β-Glucan in Colon and Gastric Cancer Cells

Saraç, BülentJoha, ZiadTakci, Rabia GökçeHacisüleyman, LeventŞahİnbaş, Burcu2026-05-122026-05-1220260250-700510.21873/anticanres.180412-s2.0-105031753611https://hdl.handle.net/123456789/1544https://doi.org/10.21873/anticanres.18041eninfo:eu-repo/semantics/closedAccessΒ-glucanGastric CancerCell CycleColon CancerPLK1ApoptosisBI-2536Synergistic Anticancer Effects of the PLK1 Inhibitor BI-2536 and β-Glucan in Colon and Gastric Cancer CellsArticle